Biotechnology
The Biotechnology industry has a total of 591 stocks, with a combined market cap of $1.35 trillion and total revenue of $115.84 billion.
Market Cap
1.35T
Revenue
115.84B
Profits
-39.58B
PE Ratio
n/a
Profit Margin
-34.17%
Dividend Yield
0.04%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 138.01B | 0.52% | 1,198,448 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 79.79B | 0.62% | 894,269 | 15.53B |
| 3 | ARGX | argenx SE | 63.60B | 0.83% | 227,992 | 5.32B |
| 4 | MRNA | Moderna, Inc. | 56.03B | 1.70% | 18,570,705 | 2.23B |
| 5 | RVMD | Revolution Medicines, Inc. | 44.06B | -1.11% | 2,269,459 | - |
| 6 | ONC | BeOne Medicines AG | 40.88B | -1.95% | 346,055 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 35.31B | 0.92% | 3,895,210 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 32.21B | 1.51% | 1,636,350 | 4.80B |
| 9 | INSM | Insmed Incorporated | 26.60B | 2.77% | 2,390,325 | 1.14B |
| 10 | BNTX | BioNTech SE | 25.52B | -0.46% | 1,089,898 | 3.03B |
| 11 | ROIV | Roivant Sciences Ltd. | 25.02B | -0.20% | 39,466,731 | 7.53M |
| 12 | INCY | Incyte Corporation | 24.98B | -0.92% | 1,483,196 | 5.82B |
| 13 | GMAB | Genmab A/S | 19.69B | -0.21% | 1,733,460 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 17.27B | 6.10% | 1,026,166 | 1.20B |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 16.27B | 2.51% | 1,221,019 | 4.60B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 14.97B | -0.01% | 2,063,611 | 713.07M |
| 17 | EXEL | Exelixis, Inc. | 13.54B | 0.35% | 2,246,348 | 2.44B |
| 18 | BMRN | BioMarin Pharmaceutical Inc. | 12.63B | 0.87% | 2,299,114 | 3.41B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.48B | 1.17% | 134,578 | 1.28B |
| 20 | CORT | Corcept Therapeutics Incorporated | 12.25B | -0.47% | 636,565 | 830.81M |
| 21 | HALO | Halozyme Therapeutics, Inc. | 12.09B | 1.08% | 1,280,007 | 1.66B |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.64B | -2.97% | 1,595,519 | 669.50M |
| 23 | TECH | Bio-Techne Corporation | 11.34B | -0.06% | 2,200,643 | 1.22B |
| 24 | SMMT | Summit Therapeutics Inc. | 10.87B | -0.80% | 5,425,209 | - |
| 25 | KRYS | Krystal Biotech, Inc. | 10.64B | 2.25% | 222,775 | 440.48M |
| 26 | ABVX | ABIVAX Société Anonyme | 10.60B | -1.43% | 1,056,740 | 5.67M |
| 27 | AXSM | Axsome Therapeutics, Inc. | 10.40B | -0.25% | 503,716 | 776.57M |
| 28 | APGE | Apogee Therapeutics, Inc. | 10.19B | 0.08% | 1,811,685 | - |
| 29 | IONS | Ionis Pharmaceuticals, Inc. | 10.03B | -1.13% | 2,017,160 | 874.09M |
| 30 | KYMR | Kymera Therapeutics, Inc. | 9.88B | 0.56% | 656,835 | 105.00M |
| 31 | CYTK | Cytokinetics, Incorporated | 9.86B | -1.64% | 3,078,140 | 67.67M |
| 32 | PRAX | Praxis Precision Medicines, Inc. | 9.78B | 1.61% | 380,663 | 7.46M |
| 33 | PTGX | Protagonist Therapeutics, Inc. | 9.56B | 2.37% | 567,396 | 281.99M |
| 34 | PCVX | Vaxcyte, Inc. | 9.04B | 1.50% | 1,748,999 | - |
| 35 | CRNX | Crinetics Pharmaceuticals, Inc. | 9.01B | 0.13% | 8,208,423 | 42.16M |
| 36 | IMVT | Immunovant, Inc. | 8.43B | -0.92% | 1,391,918 | - |
| 37 | IBRX | ImmunityBio, Inc. | 8.43B | -1.24% | 6,881,640 | 165.79M |
| 38 | SYRE | Spyre Therapeutics, Inc. | 7.88B | -1.14% | 1,913,158 | - |
| 39 | TGTX | TG Therapeutics, Inc. | 7.70B | 0.69% | 1,622,149 | 799.54M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.31B | -0.97% | 775,190 | 239.92M |
| 41 | CAI | Caris Life Sciences, Inc. | 7.20B | -0.55% | 5,867,529 | 989.61M |
| 42 | SRRK | Scholar Rock Holding Corporation | 6.92B | -1.73% | 987,265 | - |
| 43 | CGON | CG Oncology, Inc. | 6.66B | 1.10% | 840,739 | 6.23M |
| 44 | MIRM | Mirum Pharmaceuticals, Inc. | 6.37B | 0.61% | 419,813 | 618.07M |
| 45 | BLTE | Belite Bio, Inc | 6.27B | 2.63% | 146,181 | - |
| 46 | ERAS | Erasca, Inc. | 6.25B | -0.83% | 4,766,260 | - |
| 47 | TVTX | Travere Therapeutics, Inc. | 6.25B | 0.93% | 1,891,172 | 591.33M |
| 48 | ORKA | Oruka Therapeutics, Inc. | 6.13B | 1.61% | 1,292,889 | - |
| 49 | COGT | Cogent Biosciences, Inc. | 6.07B | 0.95% | 1,849,679 | - |
| 50 | DNTH | Dianthus Therapeutics, Inc. | 5.91B | -0.22% | 459,376 | 1.90M |
| 51 | XENE | Xenon Pharmaceuticals Inc. | 5.83B | 0.38% | 752,696 | 7.50M |
| 52 | PTCT | PTC Therapeutics, Inc. | 5.80B | -0.78% | 841,097 | 1.01B |
| 53 | LGND | Ligand Pharmaceuticals Incorporated | 5.66B | 1.29% | 203,702 | 290.54M |
| 54 | CRSP | CRISPR Therapeutics AG | 5.51B | -1.28% | 1,391,037 | 13.39M |
| 55 | DFTX | Definium Therapeutics, Inc. | 5.34B | -3.07% | 2,692,610 | - |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 4.98B | -0.69% | 1,035,962 | 1.14B |
| 57 | PBLS | Parabilis Medicines, Inc. | 4.82B | -0.26% | 530,036 | 148.00K |
| 58 | DYN | Dyne Therapeutics, Inc. | 4.75B | 1.44% | 2,769,268 | - |
| 59 | EWTX | Edgewise Therapeutics, Inc. | 4.54B | -2.32% | 1,085,757 | - |
| 60 | CELC | Celcuity Inc. | 4.36B | 0.70% | 818,973 | - |
| 61 | ELVN | Enliven Therapeutics, Inc. | 4.24B | 0.05% | 982,051 | - |
| 62 | MANE | Veradermics, Incorporated | 4.11B | 0.49% | 678,557 | - |
| 63 | RLAY | Relay Therapeutics, Inc. | 4.03B | -2.08% | 3,784,688 | 10.35M |
| 64 | LEGN | Legend Biotech Corporation | 4.03B | 4.53% | 2,322,503 | 1.27B |
| 65 | IDYA | IDEAYA Biosciences, Inc. | 3.87B | -0.02% | 977,809 | 234.13M |
| 66 | TNGX | Tango Therapeutics, Inc. | 3.85B | -2.14% | 1,850,353 | 53.81M |
| 67 | VKTX | Viking Therapeutics, Inc. | 3.82B | 1.93% | 1,782,497 | - |
| 68 | DNLI | Denali Therapeutics Inc. | 3.80B | -1.00% | 985,862 | 3.60M |
| 69 | TLX | Telix Pharmaceuticals Limited | 3.74B | -1.77% | 121,914 | 890.79M |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.73B | 0.24% | 1,106,428 | 117.00M |
| 71 | ABCL | AbCellera Biologics Inc. | 3.72B | 1.15% | 4,955,848 | 66.17M |
| 72 | IOVA | Iovance Biotherapeutics, Inc. | 3.70B | 2.00% | 12,126,275 | 324.97M |
| 73 | QURE | uniQure N.V. | 3.38B | -0.08% | 1,643,054 | 18.67M |
| 74 | GPCR | Structure Therapeutics Inc. | 3.27B | -3.08% | 1,394,960 | - |
| 75 | TARS | Tarsus Pharmaceuticals, Inc. | 3.26B | 3.46% | 711,972 | 606.33M |
| 76 | IMNM | Immunome, Inc. | 3.11B | -0.58% | 1,050,739 | 4.02M |
| 77 | CLDX | Celldex Therapeutics, Inc. | 3.11B | 1.30% | 696,908 | 158.00K |
| 78 | NAMS | NewAmsterdam Pharma Company N.V. | 3.03B | -2.16% | 1,546,249 | 7.12M |
| 79 | IRON | Disc Medicine, Inc. | 3.02B | -1.72% | 882,042 | - |
| 80 | ARQT | Arcutis Biotherapeutics, Inc. | 3.01B | 0.80% | 1,522,731 | 463.98M |
| 81 | MBX | MBX Biosciences, Inc. | 2.97B | -2.22% | 518,300 | - |
| 82 | BEAM | Beam Therapeutics Inc. | 2.94B | 0.38% | 1,308,774 | 156.04M |
| 83 | ZLAB | Zai Lab Limited | 2.86B | -2.38% | 920,145 | 449.61M |
| 84 | ALMS | Alumis Inc. | 2.82B | -2.55% | 1,373,435 | 7.40M |
| 85 | ATAI | AtaiBeckley Inc. | 2.72B | 0.69% | 5,221,843 | 4.47M |
| 86 | SLS | SELLAS Life Sciences Group, Inc. | 2.69B | 0.98% | 7,449,606 | - |
| 87 | NRIX | Nurix Therapeutics, Inc. | 2.68B | -1.64% | 1,244,221 | 36.77M |
| 88 | VRDN | Viridian Therapeutics, Inc. | 2.62B | 0.35% | 1,048,761 | 71.13M |
| 89 | PGEN | Precigen, Inc. | 2.48B | -0.29% | 4,135,657 | 85.72M |
| 90 | RARE | Ultragenyx Pharmaceutical Inc. | 2.48B | -1.56% | 1,934,100 | 717.00M |
| 91 | VERA | Vera Therapeutics, Inc. | 2.46B | -0.32% | 1,536,716 | - |
| 92 | NKTR | Nektar Therapeutics | 2.44B | -1.57% | 381,518 | 54.59M |
| 93 | PHVS | Pharvaris N.V. | 2.43B | -2.01% | 557,515 | - |
| 94 | TRVI | Trevi Therapeutics, Inc. | 2.37B | -1.13% | 1,872,424 | - |
| 95 | KOD | Kodiak Sciences Inc. | 2.34B | -0.98% | 1,151,643 | - |
| 96 | NUVB | Nuvation Bio Inc. | 2.34B | - | 3,199,957 | 169.90M |
| 97 | RAPP | Rapport Therapeutics, Inc. | 2.34B | -0.21% | 221,024 | 20.00M |
| 98 | BHVN | Biohaven Ltd. | 2.31B | -0.91% | 2,926,715 | - |
| 99 | OCUL | Ocular Therapeutix, Inc. | 2.30B | 1.25% | 1,520,524 | 52.06M |
| 100 | HRMY | Harmony Biosciences Holdings, Inc. | 2.29B | 0.43% | 560,160 | 959.90M |
| 101 | MLYS | Mineralys Therapeutics, Inc. | 2.27B | 0.27% | 1,078,167 | - |
| 102 | SRPT | Sarepta Therapeutics, Inc. | 2.22B | 0.81% | 2,656,895 | 1.97B |
| 103 | PVLA | Palvella Therapeutics, Inc. | 2.20B | 1.75% | 245,780 | - |
| 104 | MESO | Mesoblast Limited | 2.19B | -3.90% | 173,728 | 120.25M |
| 105 | AUPH | Aurinia Pharmaceuticals Inc. | 2.14B | -1.10% | 744,269 | 311.51M |
| 106 | COAG | Hemab Therapeutics Holdings, Inc. | 2.14B | 1.98% | 591,648 | - |
| 107 | ZBIO | Zenas BioPharma, Inc. | 2.11B | 3.36% | 527,682 | 1.00M |
| 108 | URGN | UroGen Pharma Ltd. | 2.11B | -1.22% | 749,046 | 188.73M |
| 109 | ADMA | ADMA Biologics, Inc. | 2.10B | 0.54% | 1,756,436 | 512.28M |
| 110 | ZYME | Zymeworks Inc. | 2.09B | 4.03% | 716,494 | 37.13M |
| 111 | NBTX | Nanobiotix S.A. | 2.04B | -1.43% | 113,699 | 38.27M |
| 112 | VCEL | Vericel Corporation | 2.04B | -2.56% | 636,305 | 306.30M |
| 113 | XNCR | Xencor, Inc. | 2.03B | 4.62% | 1,808,116 | 104.97M |
| 114 | STOK | Stoke Therapeutics, Inc. | 2.01B | -1.33% | 1,116,087 | 27.59M |
| 115 | AGIO | Agios Pharmaceuticals, Inc. | 2.01B | 1.08% | 1,109,643 | 98.34M |
| 116 | KLRA | Kailera Therapeutics, Inc. | 2.00B | -5.00% | 1,143,983 | - |
| 117 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.98B | -0.52% | 5,318,133 | 208.78M |
| 118 | GENB | Generate Biomedicines, Inc. | 1.96B | -0.39% | 1,552,198 | 26.48M |
| 119 | KARD | Kardigan, Inc. | 1.89B | 0.70% | 184,888 | - |
| 120 | IMCR | Immunocore Holdings plc | 1.87B | -0.82% | 271,609 | 430.78M |
| 121 | INBX | Inhibrx Biosciences, Inc. | 1.86B | 2.67% | 388,976 | 1.30M |
| 122 | TSHA | Taysha Gene Therapies, Inc. | 1.85B | -1.39% | 2,063,000 | 5.49M |
| 123 | LKFT | Lakefront Biotherapeutics NV | 1.85B | -1.32% | 133,481 | 1.13B |
| 124 | GHRS | GH Research PLC | 1.85B | -3.44% | 149,185 | - |
| 125 | VIR | Vir Biotechnology, Inc. | 1.85B | 1.02% | 3,046,562 | 303.23M |
| 126 | RXRX | Recursion Pharmaceuticals, Inc. | 1.82B | 1.80% | 13,911,890 | 54.86M |
| 127 | NTLA | Intellia Therapeutics, Inc. | 1.78B | -1.09% | 2,925,420 | 59.51M |
| 128 | SEPN | Septerna, Inc. | 1.78B | -1.95% | 415,347 | 98.88M |
| 129 | FTRE | Fortrea Holdings Inc. | 1.75B | -2.34% | 1,510,174 | 2.68B |
| 130 | DMRA | Damora Therapeutics, Inc. | 1.74B | -2.83% | 497,025 | - |
| 131 | SNDX | Syndax Pharmaceuticals, Inc. | 1.72B | -1.28% | 1,396,459 | 252.25M |
| 132 | ANAB | AnaptysBio, Inc. | 1.69B | 1.33% | 332,170 | 232.39M |
| 133 | BRVE | Braveheart Bio, Inc. | 1.64B | -7.07% | 806,210 | - |
| 134 | AAPG | Ascentage Pharma Group International | 1.57B | -6.46% | 6,059 | 94.61M |
| 135 | SLBT | SL Science Holding Limited | 1.56B | 1.11% | 16,270 | 3.27M |
| 136 | ABSI | Absci Corporation | 1.55B | 3.79% | 5,262,838 | 1.56M |
| 137 | NVAX | Novavax, Inc. | 1.55B | 1.19% | 7,271,751 | 413.80M |
| 138 | AVLN | Avalyn Pharma Inc. | 1.54B | 0.12% | 333,132 | - |
| 139 | BCAX | Bicara Therapeutics Inc. | 1.53B | -1.32% | 511,966 | - |
| 140 | LBRX | LB Pharmaceuticals Inc | 1.52B | -0.98% | 386,951 | - |
| 141 | INVA | Innoviva, Inc. | 1.50B | -0.95% | 877,333 | 440.00M |
| 142 | TRAX | First Tracks Biotherapeutics, Inc. | 1.49B | -0.05% | 686,989 | - |
| 143 | TYRA | Tyra Biosciences, Inc. | 1.49B | 0.36% | 423,798 | - |
| 144 | AVBP | ArriVent BioPharma, Inc. | 1.48B | -0.40% | 369,576 | - |
| 145 | MAZE | Maze Therapeutics, Inc. | 1.48B | -3.17% | 493,521 | 20.00M |
| 146 | APMD | Apnimed, Inc. | 1.45B | -11.65% | 475,777 | 120.15M |
| 147 | REPL | Replimune Group, Inc. | 1.44B | -1.29% | 1,701,428 | - |
| 148 | AKTS | Aktis Oncology, Inc. | 1.44B | 0.50% | 213,617 | 10.06M |
| 149 | CGEM | Cullinan Therapeutics, Inc. | 1.42B | 1.71% | 682,985 | - |
| 150 | LTGO | Latigo Biotherapeutics, Inc. | 1.39B | -9.12% | 155,038 | - |
| 151 | ANRO | Alto Neuroscience, Inc. | 1.39B | 0.71% | 764,116 | - |
| 152 | SVRA | Savara Inc. | 1.37B | 2.47% | 1,958,683 | - |
| 153 | OMER | Omeros Corporation | 1.36B | 0.97% | 1,330,487 | 38.42M |
| 154 | JBIO | Jade Biosciences, Inc. | 1.36B | 2.50% | 837,037 | - |
| 155 | ORIC | ORIC Pharmaceuticals, Inc. | 1.35B | -1.89% | 1,158,806 | - |
| 156 | VOR | Vor Biopharma Inc. | 1.33B | -0.75% | 847,990 | - |
| 157 | MGTX | MeiraGTx Holdings plc | 1.33B | -0.07% | 715,726 | 397.50M |
| 158 | DRTS | Alpha Tau Medical Ltd. | 1.30B | -3.62% | 3,116,165 | - |
| 159 | IMTX | Immatics N.V. | 1.30B | 0.85% | 725,255 | 47.65M |
| 160 | MNKD | MannKind Corporation | 1.29B | 1.52% | 2,805,986 | 393.63M |
| 161 | MLTX | MoonLake Immunotherapeutics | 1.28B | 0.40% | 1,018,116 | - |
| 162 | SPTX | Seaport Therapeutics, Inc. | 1.27B | -1.50% | 117,847 | - |
| 163 | GLUE | Monte Rosa Therapeutics, Inc. | 1.19B | 4.19% | 1,109,727 | 28.73M |
| 164 | CRVS | Corvus Pharmaceuticals, Inc. | 1.18B | -0.85% | 883,147 | - |
| 165 | ODTX | Odyssey Therapeutics, Inc. | 1.17B | 0.66% | 170,372 | 99.00K |
| 166 | SANA | Sana Biotechnology, Inc. | 1.16B | -1.53% | 2,234,429 | - |
| 167 | KURA | Kura Oncology, Inc. | 1.13B | -0.08% | 1,964,708 | 77.23M |
| 168 | JANX | Janux Therapeutics, Inc. | 1.11B | 1.05% | 712,590 | 24.00M |
| 169 | IVA | Inventiva S.A. | 1.11B | -0.53% | 1,004,220 | 7.94M |
| 170 | AVTX | Avalo Therapeutics, Inc. | 1.04B | -1.28% | 1,377,267 | 59.00K |
| 171 | SLDB | Solid Biosciences Inc. | 1.03B | -1.94% | 686,620 | - |
| 172 | ABUS | Arbutus Biopharma Corporation | 1.01B | 0.20% | 3,562,202 | 181.72M |
| 173 | IMMX | Immix Biopharma, Inc. | 1.00B | 0.65% | 1,326,817 | - |
| 174 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.00B | -1.75% | 6,653,032 | 41.47M |
| 175 | CADL | Candel Therapeutics, Inc. | 1.00B | - | 895,014 | - |
| 176 | WVE | Wave Life Sciences, Inc. | 965.54M | -2.78% | 3,811,756 | 65.37M |
| 177 | GERN | Geron Corporation | 957.29M | -1.32% | 7,247,302 | 204.56M |
| 178 | DSGN | Design Therapeutics, Inc. | 944.36M | -0.13% | 704,386 | - |
| 179 | ARDX | Ardelyx, Inc. | 941.93M | -0.79% | 3,801,734 | 450.89M |
| 180 | ANNX | Annexon, Inc. | 936.52M | -0.60% | 2,436,869 | - |
| 181 | ATTO | Attovia Therapeutics, Inc. | 920.82M | 3.38% | 181,376 | 1.35M |
| 182 | ANL | Adlai Nortye Group Ltd. | 913.81M | 2.68% | 139,189 | 18.06M |
| 183 | OLMA | Olema Pharmaceuticals, Inc. | 912.60M | 1.56% | 937,029 | - |
| 184 | ACRS | Aclaris Therapeutics, Inc. | 890.55M | 0.67% | 1,633,151 | 8.22M |
| 185 | TBPH | Theravance Biopharma, Inc. | 884.70M | -0.06% | 383,660 | 104.31M |
| 186 | SGP | SpyGlass Pharma, Inc. | 872.99M | -1.21% | 64,812 | - |
| 187 | RIGL | Rigel Pharmaceuticals, Inc. | 862.64M | -0.65% | 243,090 | 276.79M |
| 188 | HELP | Cybin Inc. | 859.19M | -3.45% | 1,479,283 | - |
| 189 | FTH | Faeth Therapeutics, Inc. | 846.79M | -3.16% | 173,127 | - |
| 190 | ACHV | Achieve Life Sciences, Inc. | 817.05M | -1.98% | 1,059,972 | - |
| 191 | DBVT | DBV Technologies S.A. | 815.91M | 2.07% | 179,194 | 5.04M |
| 192 | SLN | Silence Therapeutics plc | 814.63M | 0.82% | 478,195 | 615.00K |
| 193 | PHAR | Pharming Group N.V. | 811.69M | -1.88% | 12,357 | 366.48M |
| 194 | CLYM | Climb Bio, Inc. | 788.60M | -5.77% | 1,437,486 | - |
| 195 | FDMT | 4D Molecular Therapeutics, Inc. | 779.50M | -3.82% | 1,404,178 | 92.01M |
| 196 | PHAT | Phathom Pharmaceuticals, Inc. | 760.15M | 4.25% | 1,211,544 | 239.66M |
| 197 | OBX | Obsidian Therapeutics, Inc. | 758.64M | 7.42% | 142,522 | - |
| 198 | OCS | Oculis Holding AG | 756.22M | 0.33% | 114,053 | 1.45M |
| 199 | MNPR | Monopar Therapeutics Inc. | 751.29M | 0.04% | 141,854 | - |
| 200 | AURA | Aura Biosciences, Inc. | 744.60M | -2.97% | 602,504 | - |
| 201 | NVCT | Nuvectis Pharma, Inc. | 740.58M | -4.21% | 192,565 | - |
| 202 | CTMX | CytomX Therapeutics, Inc. | 732.14M | 4.67% | 2,381,134 | 18.30M |
| 203 | NGNE | Neurogene Inc. | 725.21M | -0.93% | 120,389 | 925.00K |
| 204 | MPLT | MapLight Therapeutics, Inc. | 720.82M | 2.94% | 440,580 | - |
| 205 | CBIO | Crescent Biopharma, Inc. | 710.50M | -6.48% | 162,999 | 11.88M |
| 206 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 705.53M | 0.69% | 476,039 | - |
| 207 | STTK | Shattuck Labs, Inc. | 703.55M | -0.43% | 751,226 | 1.00M |
| 208 | DRUG | Bright Minds Biosciences Inc. | 700.83M | -1.48% | 52,438 | - |
| 209 | ZVRA | Zevra Therapeutics, Inc. | 697.17M | 1.47% | 818,901 | 136.07M |
| 210 | GYRE | Gyre Therapeutics, Inc. | 696.64M | -0.30% | 41,715 | 109.82M |
| 211 | ALLO | Allogene Therapeutics, Inc. | 690.98M | -0.99% | 4,376,901 | 4.64M |
| 212 | ASMB | Assembly Biosciences, Inc. | 684.73M | -1.29% | 235,972 | 74.85M |
| 213 | MDXG | MiMedx Group, Inc. | 661.75M | 0.89% | 1,063,480 | 355.17M |
| 214 | VSTM | Verastem, Inc. | 653.87M | - | 1,324,422 | 87.53M |
| 215 | AGMB | AgomAb Therapeutics NV | 648.60M | - | 105,443 | - |
| 216 | CRMD | CorMedix Inc. | 643.82M | -0.48% | 980,536 | 462.25M |
| 217 | PRME | Prime Medicine, Inc. | 638.68M | -0.55% | 2,092,566 | 4.07M |
| 218 | SGMT | Sagimet Biosciences Inc. | 637.75M | -2.75% | 688,437 | - |
| 219 | OABI | OmniAb, Inc. | 636.81M | -2.01% | 1,179,889 | 38.46M |
| 220 | RGNX | REGENXBIO Inc. | 627.13M | -1.66% | 1,612,317 | 174.48M |
| 221 | AUTL | Autolus Therapeutics plc | 625.48M | 0.43% | 1,197,017 | 117.39M |
| 222 | CTNM | Contineum Therapeutics, Inc. | 610.97M | -4.75% | 360,162 | - |
| 223 | ALT | Altimmune, Inc. | 604.95M | - | 2,216,476 | 31.00K |
| 224 | ARVN | Arvinas, Inc. | 601.55M | 0.22% | 659,721 | 316.70M |
| 225 | SPRY | ARS Pharmaceuticals, Inc. | 596.68M | 1.87% | 1,984,647 | 116.93M |
| 226 | VALN | Valneva SE | 596.47M | -2.02% | 11,553 | 163.30M |
| 227 | TECX | Tectonic Therapeutic, Inc. | 585.31M | -15.95% | 719,570 | - |
| 228 | PRLD | Prelude Therapeutics Incorporated | 576.77M | 2.38% | 737,667 | 22.42M |
| 229 | CAPR | Capricor Therapeutics, Inc. | 576.16M | 3.34% | 4,558,778 | 11.13M |
| 230 | SCTX | Scribe Therapeutics Inc. | 576.12M | 7.38% | 151,094 | 36.28M |
| 231 | PROK | ProKidney Corp. | 571.39M | 3.28% | 1,261,896 | 818.00K |
| 232 | EIKN | Eikon Therapeutics, Inc. | 566.57M | -4.74% | 290,729 | - |
| 233 | BLSM | BlossomHill Therapeutics, Inc. | 560.78M | -6.44% | 101,562 | - |
| 234 | ARTV | Artiva Biotherapeutics, Inc. | 552.46M | 1.89% | 249,844 | 251.00K |
| 235 | ZURA | Zura Bio Limited | 530.89M | -3.15% | 1,383,179 | - |
| 236 | CABA | Cabaletta Bio, Inc. | 527.29M | -0.32% | 3,030,486 | - |
| 237 | KYTX | Kyverna Therapeutics, Inc. | 524.12M | 1.25% | 484,454 | - |
| 238 | OVID | Ovid Therapeutics Inc. | 521.45M | -4.64% | 1,392,943 | 1.58M |
| 239 | ENTX | Entera Bio Ltd. | 510.77M | -2.64% | 214,455 | 42.00K |
| 240 | RZLT | Rezolute, Inc. | 489.95M | 1.52% | 749,091 | - |
| 241 | PRTA | Prothena Corporation plc | 480.00M | 0.21% | 335,150 | 54.53M |
| 242 | VOGX | Vogenx, Inc. | 473.20M | 0.12% | 26,001 | - |
| 243 | PBYI | Puma Biotechnology, Inc. | 470.26M | 0.55% | 242,883 | 231.24M |
| 244 | EDIT | Editas Medicine, Inc. | 469.95M | -3.16% | 2,076,018 | 47.01M |
| 245 | RLMD | Relmada Therapeutics, Inc. | 465.08M | 0.69% | 628,243 | - |
| 246 | EVMN | Evommune, Inc. | 459.46M | -4.31% | 571,963 | 10.00M |
| 247 | DNA | Ginkgo Bioworks Holdings, Inc. | 458.59M | -2.16% | 1,209,393 | 132.42M |
| 248 | CCCC | C4 Therapeutics, Inc. | 456.42M | -3.64% | 1,857,546 | 35.04M |
| 249 | OCGN | Ocugen, Inc. | 451.02M | 0.76% | 4,663,344 | 4.58M |
| 250 | QTTB | Q32 Bio Inc. | 442.67M | -1.06% | 349,854 | 53.74M |
| 251 | FENC | Fennec Pharmaceuticals Inc. | 433.08M | 0.65% | 508,685 | 59.22M |
| 252 | CMPX | Compass Therapeutics, Inc. | 430.41M | -0.42% | 3,523,043 | 850.00K |
| 253 | AVIR | Atea Pharmaceuticals, Inc. | 429.10M | -0.19% | 198,433 | - |
| 254 | EPRX | Eupraxia Pharmaceuticals Inc. | 426.43M | -3.29% | 370,701 | - |
| 255 | IKT | Inhibikase Therapeutics, Inc. | 420.59M | -4.15% | 329,873 | 1.00 |
| 256 | ARCT | Arcturus Therapeutics Holdings Inc. | 419.52M | -2.83% | 1,261,085 | 29.37M |
| 257 | BNTC | Benitec Biopharma Inc. | 418.09M | -2.41% | 60,834 | - |
| 258 | RCKT | Rocket Pharmaceuticals, Inc. | 408.36M | -3.63% | 1,603,826 | - |
| 259 | XFOR | X4 Pharmaceuticals, Inc. | 400.55M | - | 245,892 | 15.85M |
| 260 | LRMR | Larimar Therapeutics, Inc. | 398.74M | -4.74% | 1,066,012 | - |
| 261 | GALT | Galectin Therapeutics Inc. | 398.36M | -1.74% | 229,714 | - |
| 262 | VTVT | vTv Therapeutics Inc. | 397.59M | -1.11% | 94,153 | 36.84M |
| 263 | LXEO | Lexeo Therapeutics, Inc. | 390.52M | -2.06% | 472,038 | - |
| 264 | ENTA | Enanta Pharmaceuticals, Inc. | 388.24M | -1.99% | 286,516 | 65.26M |
| 265 | EYPT | EyePoint, Inc. | 387.95M | 0.45% | 3,506,366 | 2.79M |
| 266 | IPSC | Century Therapeutics, Inc. | 371.20M | 1.23% | 374,208 | 109.16M |
| 267 | UPB | Upstream Bio, Inc. | 362.58M | -1.05% | 895,009 | 3.16M |
| 268 | ZNTL | Zentalis Pharmaceuticals, Inc. | 355.97M | -1.05% | 471,813 | 26.87M |
| 269 | LYEL | Lyell Immunopharma, Inc. | 350.91M | -1.45% | 62,771 | 27.00K |
| 270 | AGEN | Agenus Inc. | 342.61M | -0.65% | 721,032 | 132.69M |
| 271 | DMAC | DiaMedica Therapeutics Inc. | 342.43M | -0.63% | 135,125 | - |
| 272 | FHTX | Foghorn Therapeutics Inc. | 340.87M | -4.33% | 305,574 | 36.74M |
| 273 | PALI | Palisade Bio, Inc. | 339.83M | -2.50% | 1,645,808 | 500.00K |
| 274 | SABS | SAB Biotherapeutics, Inc. | 337.56M | -2.11% | 201,144 | 114.70K |
| 275 | STRO | Sutro Biopharma, Inc. | 335.60M | -1.03% | 169,297 | 45.70M |
| 276 | ABEO | Abeona Therapeutics Inc. | 334.53M | -1.18% | 993,556 | 25.52M |
| 277 | VNDA | Vanda Pharmaceuticals Inc. | 326.50M | 2.08% | 777,316 | 215.72M |
| 278 | IMRX | Immuneering Corporation | 322.84M | - | 587,881 | - |
| 279 | IFRX | InflaRx N.V. | 313.89M | -4.48% | 447,812 | -11.54K |
| 280 | VCRE | Vicore Pharma Holding AB (publ) | 303.27M | -2.39% | 9,579 | 412.09K |
| 281 | OBIO | Orchestra BioMed Holdings, Inc. | 302.93M | -2.89% | 276,551 | 31.98M |
| 282 | IRD | Opus Genetics, Inc. | 301.17M | -1.90% | 584,222 | 9.86M |
| 283 | PRQR | ProQR Therapeutics N.V. | 300.59M | -6.99% | 943,524 | 21.05M |
| 284 | FULC | Fulcrum Therapeutics, Inc. | 296.80M | 1.04% | 1,798,204 | 80.00M |
| 285 | CUVL | Clinuvel Pharmaceuticals Limited | 289.65M | -3.41% | 42,906 | 65.05M |
| 286 | BCYC | Bicycle Therapeutics plc | 289.07M | -1.67% | 235,608 | 61.21M |
| 287 | FATE | Fate Therapeutics, Inc. | 286.37M | -1.65% | 549,269 | 6.49M |
| 288 | TTRX | Turn Therapeutics Inc. | 285.97M | -2.44% | 31,636 | - |
| 289 | IVVD | Invivyd, Inc. | 281.47M | -1.00% | 3,498,160 | 58.37M |
| 290 | RNAC | Cartesian Therapeutics, Inc. | 280.77M | -3.33% | 90,808 | 1.48M |
| 291 | LCTX | Lineage Cell Therapeutics, Inc. | 278.20M | -0.90% | 583,453 | 13.08M |
| 292 | SION | Sionna Therapeutics, Inc. | 272.63M | 2.73% | 1,383,775 | - |
| 293 | PYXS | Pyxis Oncology, Inc. | 270.24M | 0.31% | 469,508 | 11.04M |
| 294 | ALXO | ALX Oncology Holdings Inc. | 266.87M | -3.50% | 349,439 | - |
| 295 | ACIU | AC Immune SA | 262.49M | -0.38% | 132,959 | 21.67M |
| 296 | YDES | YD Bio Limited | 260.89M | -22.71% | 445,425 | 510.36K |
| 297 | AVXL | Anavex Life Sciences Corp. | 259.55M | -6.35% | 1,034,003 | - |
| 298 | WHWK | Whitehawk Therapeutics, Inc. | 258.82M | -1.73% | 359,275 | 7.15M |
| 299 | SRZN | Surrozen, Inc. | 258.81M | -1.78% | 266,750 | 11.51M |
| 300 | TRDA | Entrada Therapeutics, Inc. | 254.20M | 0.71% | 450,412 | 4.69M |
| 301 | MGNX | MacroGenics, Inc. | 254.16M | -3.39% | 542,802 | 175.14M |
| 302 | ALEC | Alector, Inc. | 252.34M | -3.42% | 610,060 | 13.86M |
| 303 | NMRA | Neumora Therapeutics, Inc. | 249.90M | -4.32% | 633,100 | - |
| 304 | CAMP | Camp4 Therapeutics Corporation | 248.50M | -4.58% | 190,292 | 4.22M |
| 305 | NAGE | Niagen Bioscience, Inc. | 248.19M | -4.86% | 477,591 | 129.08M |
| 306 | CLLS | Cellectis S.A. | 247.73M | -1.47% | 13,187 | 63.82M |
| 307 | CGEN | Compugen Ltd. | 242.49M | -1.54% | 175,118 | 74.00M |
| 308 | ELDN | Eledon Pharmaceuticals, Inc. | 242.40M | -6.88% | 1,836,684 | - |
| 309 | TNXP | Tonix Pharmaceuticals Holding Corp. | 241.83M | 3.75% | 568,793 | 29.10M |
| 310 | NGEN | NervGen Pharma Corp. | 237.63M | -3.07% | 798,260 | - |
| 311 | ADAG | Adagene Inc. | 235.67M | -4.62% | 131,615 | 9.29M |
| 312 | TARA | Protara Therapeutics, Inc. | 228.11M | 1.05% | 506,469 | - |
| 313 | RNA | Atrium Therapeutics, Inc. | 227.85M | -2.35% | 97,049 | 35.84M |
| 314 | SLGL | Sol-Gel Technologies Ltd. | 226.23M | 0.42% | 111,452 | 1.80M |
| 315 | KROS | Keros Therapeutics, Inc. | 219.69M | 0.45% | 179,962 | 15.01M |
| 316 | GLSI | Greenwich LifeSciences, Inc. | 219.44M | -4.59% | 169,639 | - |
| 317 | NERV | Minerva Neurosciences, Inc. | 217.73M | -5.79% | 116,334 | - |
| 318 | IMUX | Immunic, Inc. | 215.58M | 2.60% | 124,872 | - |
| 319 | VYGR | Voyager Therapeutics, Inc. | 212.58M | -2.54% | 395,564 | 34.46M |
| 320 | NBP | NovaBridge Biosciences | 211.12M | -1.09% | 273,731 | - |
| 321 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 211.01M | - | 473,590 | - |
| 322 | DTIL | Precision BioSciences, Inc. | 210.88M | -1.80% | 214,810 | 45.06M |
| 323 | ANTX | AN2 Therapeutics, Inc. | 209.44M | -0.54% | 124,021 | - |
| 324 | ORMP | Oramed Pharmaceuticals Inc. | 208.82M | -0.20% | 242,855 | 2.00M |
| 325 | CHRS | Coherus Oncology, Inc. | 208.58M | -4.26% | 1,128,491 | 50.94M |
| 326 | PEPG | PepGen Inc. | 207.09M | -2.92% | 365,815 | - |
| 327 | PLX | Protalix BioTherapeutics, Inc. | 207.07M | 1.18% | 748,351 | 80.62M |
| 328 | ABOS | Acumen Pharmaceuticals, Inc. | 206.10M | -2.40% | 244,217 | - |
| 329 | ARMP | Armata Pharmaceuticals, Inc. | 204.87M | 2.61% | 51,488 | 5.54M |
| 330 | ACOG | Alpha Cognition Inc. | 201.88M | 1.20% | 215,624 | 15.26M |
| 331 | IPHA | Innate Pharma S.A. | 201.15M | -2.25% | 9,962 | 10.57M |
| 332 | MSLE | Satellos Bioscience Inc. | 199.10M | 7.85% | 53,274 | - |
| 333 | NKTX | Nkarta, Inc. | 194.10M | -1.81% | 481,575 | - |
| 334 | CNXU | Conexeu Sciences Inc. | 191.99M | 1.49% | 190,251 | - |
| 335 | CDXS | Codexis, Inc. | 186.16M | 6.92% | 1,388,937 | 77.68M |
| 336 | CUE | Cue Biopharma, Inc. | 185.39M | -8.46% | 101,119 | 37.66M |
| 337 | KRRO | Korro Bio, Inc. | 183.92M | -3.25% | 87,957 | 2.38M |
| 338 | CNTN | Canton Strategic Holdings, Inc. | 181.67M | 2.70% | 407,219 | 1.50M |
| 339 | SPRB | Spruce Biosciences, Inc. | 169.48M | -2.98% | 44,939 | 697.00K |
| 340 | MOLN | Molecular Partners AG | 169.15M | - | - | 856.30K |
| 341 | HUMA | Humacyte, Inc. | 167.07M | -7.49% | 13,537,584 | 2.12M |
| 342 | MENS | Jyong Biotech Ltd. | 165.54M | -5.91% | 63,234 | - |
| 343 | CRBU | Caribou Biosciences, Inc. | 165.10M | -4.94% | 1,010,332 | 10.04M |
| 344 | LENZ | LENZ Therapeutics, Inc. | 163.70M | 1.96% | 713,740 | 21.48M |
| 345 | MIST | Milestone Pharmaceuticals Inc. | 163.46M | - | 1,003,721 | 2.34M |
| 346 | MDWD | MediWound Ltd. | 162.80M | -0.39% | 167,025 | 11.86M |
| 347 | KZIA | Kazia Therapeutics Limited | 157.35M | 1.40% | 379,865 | 1.27M |
| 348 | TNYA | Tenaya Therapeutics, Inc. | 154.23M | -0.33% | 1,506,951 | 1.34M |
| 349 | OTLK | Outlook Therapeutics, Inc. | 154.20M | -1.78% | 6,431,455 | -1.16M |
| 350 | INDP | Indaptus Therapeutics, Inc. | 152.56M | 0.44% | 140,263 | - |
| 351 | NRXP | NRx Pharmaceuticals, Inc. | 150.55M | -1.97% | 427,013 | 3.39M |
| 352 | OKUR | OnKure Therapeutics, Inc. | 147.00M | -4.22% | 100,479 | - |
| 353 | UNCY | Unicycive Therapeutics, Inc. | 144.85M | -1.33% | 578,042 | - |
| 354 | EQ | Equillium, Inc. | 143.94M | -5.02% | 288,983 | 4.39M |
| 355 | CNTB | Connect Biopharma Holdings Limited | 138.54M | -1.35% | 571,346 | 2.95M |
| 356 | HURA | TuHURA Biosciences, Inc. | 135.74M | 0.95% | 233,421 | - |
| 357 | AARD | Aardvark Therapeutics, Inc. | 133.50M | 5.35% | 125,436 | - |
| 358 | INO | Inovio Pharmaceuticals, Inc. | 131.31M | -1.55% | 5,628,025 | 65.34K |
| 359 | TLSA | Tiziana Life Sciences Ltd | 127.76M | -2.18% | 429,931 | - |
| 360 | VANI | Vivani Medical, Inc. | 125.38M | -2.11% | 208,215 | - |
| 361 | CBUS | Cibus, Inc. | 123.81M | -1.82% | 91,763 | 4.35M |
| 362 | NAUT | Nautilus Biotechnology, Inc. | 123.74M | 9.79% | 785,284 | 190.00K |
| 363 | ENGN | enGene Therapeutics Inc. | 123.26M | 0.82% | 291,275 | - |
| 364 | NTHI | NeOnc Technologies Holdings, Inc. | 122.79M | 5.33% | 174,631 | 39.99K |
| 365 | BMEA | Biomea Fusion, Inc. | 121.77M | -2.89% | 1,018,961 | - |
| 366 | BDTX | Black Diamond Therapeutics, Inc. | 120.65M | -5.83% | 509,283 | 70.00M |
| 367 | RANI | Rani Therapeutics Holdings, Inc. | 119.02M | 1.64% | 382,589 | 4.88M |
| 368 | PMN | ProMIS Neurosciences, Inc. | 117.21M | -5.22% | 24,570 | - |
| 369 | GNLX | Genelux Corporation | 117.18M | -1.69% | 328,487 | 8.00K |
| 370 | ANIX | Anixa Biosciences, Inc. | 113.98M | -3.74% | 353,288 | - |
| 371 | GUTS | Fractyl Health, Inc. | 113.15M | 7.86% | 1,781,115 | 3.00K |
| 372 | SEER | Seer, Inc. | 108.53M | -1.01% | 145,122 | 14.22M |
| 373 | COYA | Coya Therapeutics, Inc. | 106.96M | -0.65% | 47,433 | 8.02M |
| 374 | ONCY | Oncolytics Biotech Inc. | 106.88M | -2.15% | 436,008 | - |
| 375 | TENX | Tenax Therapeutics, Inc. | 105.40M | -13.62% | 17,237,412 | - |
| 376 | PYPD | PolyPid Ltd. | 104.40M | 1.38% | 56,033 | - |
| 377 | PLYX | Polaryx Therapeutics, Inc. | 100.19M | -2.43% | 41,438 | - |
| 378 | CGTX | Cognition Therapeutics, Inc. | 97.95M | 0.98% | 294,606 | - |
| 379 | KLRS | Kalaris Therapeutics, Inc. | 96.17M | 0.25% | 19,587 | - |
| 380 | VRCA | Verrica Pharmaceuticals Inc. | 93.80M | -4.04% | 106,419 | 30.32M |
| 381 | ACET | Adicet Bio, Inc. | 93.65M | -3.97% | 112,001 | - |
| 382 | YARW | Yarrow Bioscience, Inc. | 92.29M | -10.92% | 83,097 | - |
| 383 | PTHS | Pelthos Therapeutics Inc. | 92.19M | -2.63% | 79,242 | 43.30M |
| 384 | FBIO | Fortress Biotech, Inc. | 91.21M | -1.26% | 326,338 | 68.47M |
| 385 | ACRV | Acrivon Therapeutics, Inc. | 89.56M | 1.46% | 160,288 | - |
| 386 | ATRA | Atara Biotherapeutics, Inc. | 89.34M | -3.26% | 30,242 | 6.19M |
| 387 | ALDX | Aldeyra Therapeutics, Inc. | 89.28M | -0.34% | 495,386 | - |
| 388 | RLYB | Rallybio Corporation | 89.16M | -0.12% | 14,139 | 646.00K |
| 389 | ICCC | ImmuCell Corporation | 88.91M | -1.51% | 20,134 | 30.68M |
| 390 | DWTX | Dogwood Therapeutics, Inc. | 87.70M | -2.64% | 64,361 | - |
| 391 | RNXT | RenovoRx, Inc. | 87.10M | 15.57% | 3,294,194 | 1.98M |
| 392 | GOSS | Gossamer Bio, Inc. | 83.10M | -0.06% | 10,148,748 | 53.29M |
| 393 | OKYO | OKYO Pharma Limited | 79.77M | -8.98% | 63,901 | - |
| 394 | MAIA | MAIA Biotechnology, Inc. | 79.68M | -1.50% | 258,682 | - |
| 395 | GANX | Gain Therapeutics, Inc. | 78.56M | 1.69% | 259,893 | - |
| 396 | OSTX | OS Therapies Incorporated | 77.95M | 3.05% | 234,958 | - |
| 397 | ATHE | Alterity Therapeutics Limited | 77.89M | -0.44% | 8,709 | 3.69M |
| 398 | CRDF | Cardiff Oncology, Inc. | 77.30M | 5.70% | 593,645 | 508.00K |
| 399 | TELO | Telomir Pharmaceuticals, Inc. | 77.03M | -1.75% | 45,432 | - |
| 400 | NRXS | NeurAxis, Inc. | 75.47M | 0.17% | 52,623 | 5.32M |
| 401 | CING | Cingulate Inc. | 75.18M | -3.00% | 202,394 | - |
| 402 | LONA | LeonaBio, Inc. | 74.62M | -0.25% | 34,164 | - |
| 403 | ANVS | Annovis Bio, Inc. | 73.28M | - | 425,505 | - |
| 404 | SPRO | Spero Therapeutics, Inc. | 71.05M | 1.67% | 338,466 | 47.00M |
| 405 | ELTX | Elicio Therapeutics, Inc. | 70.96M | -4.93% | 412,187 | - |
| 406 | MNOV | MediciNova, Inc. | 70.63M | - | 18,670 | 920.48K |
| 407 | XBIT | XBiotech Inc. | 70.12M | 1.32% | 23,052 | - |
| 408 | CSBR | Champions Oncology, Inc. | 69.40M | 1.32% | 745 | 59.43M |
| 409 | PLRX | Pliant Therapeutics, Inc. | 68.11M | -0.90% | 400,005 | - |
| 410 | ELOX | Eloxx Pharmaceuticals, Inc. | 67.69M | 11.28% | 38,899 | - |
| 411 | BSEM | BioStem Technologies, Inc. | 65.69M | 4.25% | 196,440 | 34.59M |
| 412 | ALPS | Alps Group Inc | 64.88M | 1.30% | 36,787 | 3.74M |
| 413 | RNTX | Rein Therapeutics Inc. | 64.69M | -1.60% | 546,084 | - |
| 414 | PMVP | PMV Pharmaceuticals, Inc. | 64.68M | -0.82% | 1,115,523 | - |
| 415 | EDSA | Edesa Biotech, Inc. | 63.98M | 2.49% | 91,748 | - |
| 416 | BOLD | Boundless Bio, Inc. | 63.92M | -0.71% | 103,238 | - |
| 417 | INMB | INmune Bio Inc. | 63.83M | -1.29% | 295,261 | 50.00K |
| 418 | IBIO | iBio, Inc. | 63.09M | -6.62% | 875,831 | 100.00K |
| 419 | HYFT | MindWalk Holdings Corp. | 62.96M | -3.60% | 55,679 | 11.43M |
| 420 | EXOZ | eXoZymes, Inc. | 62.46M | -6.14% | 842 | -700.00 |
| 421 | SER | Serina Therapeutics, Inc. | 61.47M | -1.63% | 23,117 | 130.00K |
| 422 | HRTX | Heron Therapeutics, Inc. | 60.37M | -2.63% | 2,132,634 | 151.18M |
| 423 | APLM | Apollomics, Inc. | 59.49M | 1.84% | 3,214 | 8.84M |
| 424 | XLO | Xilio Therapeutics, Inc. | 58.89M | -0.56% | 14,571 | 64.09M |
| 425 | IMA | ImageneBio, Inc. | 57.89M | -4.49% | 24,601 | 800.00K |
| 426 | INKT | MiNK Therapeutics, Inc. | 56.59M | -2.97% | 11,883 | - |
| 427 | CELU | Celularity Inc. | 53.55M | 17.09% | 3,422,194 | 26.55M |
| 428 | HYPD | Hyperion DeFi, Inc. | 53.14M | 4.91% | 445,402 | 1.40M |
| 429 | NTRB | Nutriband Inc. | 53.09M | -2.09% | 25,819 | 1.80M |
| 430 | ATYR | aTyr Pharma, Inc. | 52.15M | -1.54% | 1,023,604 | 190.00K |
| 431 | TIL | Instil Bio, Inc. | 51.61M | 0.40% | 2,601 | - |
| 432 | IMMP | Immutep Limited | 50.66M | -3.94% | 177,131 | 13.79M |
| 433 | IBO | Impact BioMedical Inc. | 49.72M | 3.93% | 8,407 | 35.00K |
| 434 | TCRX | TScan Therapeutics, Inc. | 49.46M | -3.16% | 330,387 | 7.11M |
| 435 | MCRB | Seres Therapeutics, Inc. | 48.81M | -3.91% | 44,226 | 1.88M |
| 436 | VERU | Veru Inc. | 47.74M | 6.67% | 250,048 | 16.89M |
| 437 | KPTI | Karyopharm Therapeutics Inc. | 46.72M | 10.16% | 2,028,980 | 146.62M |
| 438 | HOWL | Werewolf Therapeutics, Inc. | 45.73M | -0.24% | 1,268,276 | 21.00M |
| 439 | TVGN | Tevogen Inc. | 45.45M | 1.31% | 8,550 | - |
| 440 | GRCE | Grace Therapeutics, Inc. | 44.81M | 0.47% | 117,306 | - |
| 441 | MGX | Metagenomi Therapeutics, Inc. | 44.58M | -0.84% | 106,861 | 13.56M |
| 442 | FLNA | Filana Therapeutics, Inc. | 43.38M | -3.34% | 140,018 | - |
| 443 | MREO | Mereo BioPharma Group plc | 42.61M | 5.66% | 1,314,939 | 500.00K |
| 444 | CRVO | CervoMed Inc. | 39.76M | 1.15% | 94,999 | 331.30K |
| 445 | ALGS | Aligos Therapeutics, Inc. | 36.59M | -15.20% | 98,916 | 31.52M |
| 446 | ACTU | Actuate Therapeutics, Inc. | 36.50M | -8.16% | 274,736 | - |
| 447 | CNTX | Context Therapeutics Inc. | 35.81M | 1.56% | 1,280,727 | - |
| 448 | RNAZ | TransCode Therapeutics, Inc. | 35.55M | -3.67% | 838,251 | - |
| 449 | VRXA | Veraxa Biotech AG | 34.04M | - | 296,521 | 29.54K |
| 450 | LITS | Lite Strategy, Inc. | 33.53M | 0.52% | 106,763 | - |
| 451 | QNCX | Quince Therapeutics, Inc. | 33.13M | -3.50% | 34,168 | - |
| 452 | ATNM | Actinium Pharmaceuticals, Inc. | 32.07M | 0.99% | 34,778 | 35.09M |
| 453 | ESLA | Estrella Immunopharma, Inc. | 31.54M | 2.82% | 13,121 | - |
| 454 | KYNB | Kyntra Bio, Inc. | 31.50M | -2.99% | 30,752 | 4.62M |
| 455 | BCTX | BriaCell Therapeutics Corp. | 31.19M | -3.75% | 260,695 | - |
| 456 | RADX | Radiopharm Theranostics Limited | 31.06M | -5.39% | 49,624 | 8.74M |
| 457 | IGC | IGC Pharma, Inc. | 30.93M | -3.48% | 619,130 | 1.11M |
| 458 | NXTC | NextCure, Inc. | 29.25M | 4.93% | 54,890 | - |
| 459 | CVM | CEL-SCI Corporation | 28.49M | 3.85% | 56,390 | - |
| 460 | NNVC | NanoViricides, Inc. | 28.48M | 0.81% | 399,355 | - |
| 461 | BRNS | Barinthus Biotherapeutics plc | 28.47M | -6.61% | 196,991 | 14.97M |
| 462 | PLRZ | Polyrizon Ltd. | 27.16M | 10.34% | 45,028 | - |
| 463 | GRDX | GridAI Technologies Corp. | 26.34M | -6.08% | 40,908 | - |
| 464 | LTRN | Lantern Pharma Inc. | 25.95M | -1.93% | 107,966 | - |
| 465 | QNTM | Quantum BioPharma Ltd. | 25.90M | 3.09% | 82,250 | - |
| 466 | BYSI | BeyondSpring Inc. | 25.51M | -6.75% | 55,843 | 1.88M |
| 467 | EVAX | Evaxion A/S | 25.02M | -0.33% | 102,017 | 7.49M |
| 468 | ATOS | Atossa Therapeutics, Inc. | 24.95M | -3.10% | 53,195 | - |
| 469 | GNTA | Genenta Science S.p.A. | 24.06M | 2.00% | 24,780 | - |
| 470 | TVRD | Tvardi Therapeutics, Inc. | 24.01M | -1.10% | 118,582 | - |
| 471 | CLRB | Cellectar Biosciences, Inc. | 23.72M | -0.79% | 17,294 | - |
| 472 | JSPR | Jasper Therapeutics, Inc. | 23.67M | 1.67% | 388,436 | - |
| 473 | ALLR | Allarity Therapeutics, Inc. | 22.43M | - | 106,345 | 345.00K |
| 474 | ENLV | Enlivex Ltd. | 22.38M | -5.19% | 403,712 | - |
| 475 | COCP | Cocrystal Pharma, Inc. | 22.35M | 5.45% | 48,490 | 330.00K |
| 476 | ABVC | ABVC BioPharma, Inc. | 22.23M | 3.31% | 113,481 | 797.92K |
| 477 | MRKR | Marker Therapeutics, Inc. | 22.18M | -2.92% | 59,540 | 3.55M |
| 478 | LGVN | Longeveron Inc. | 22.00M | 2.68% | 106,931 | 1.19M |
| 479 | CNSY | Cerenome, Inc. | 21.40M | -7.54% | 117,545 | 4.20M |
| 480 | PTN | Palatin Technologies, Inc. | 20.34M | -4.68% | 153,247 | 12.88M |
| 481 | NEUP | Neuphoria Therapeutics Inc. | 20.32M | - | 52,204 | -13.27K |
| 482 | AKTX | Akari Therapeutics, Plc | 20.31M | -2.52% | 81,397 | - |
| 483 | DYAI | Dyadic International, Inc. | 20.23M | -9.61% | 261,914 | 3.80M |
| 484 | NIKI | Niki BioSolutions, Inc. | 20.16M | -0.58% | 94,803 | - |
| 485 | CMMB | Chemomab Therapeutics Ltd. | 19.71M | 0.37% | 42,186 | - |
| 486 | KTTA | Pasithea Therapeutics Corp. | 19.18M | 2.50% | 450,589 | - |
| 487 | NCEL | NewcelX Ltd. | 18.92M | 2.66% | 13,871 | - |
| 488 | LEXX | Lexaria Bioscience Corp. | 18.64M | 8.99% | 359,550 | 194.00K |
| 489 | LPCN | Lipocine Inc. | 18.47M | 3.23% | 27,530 | 1.57M |
| 490 | TPST | Tempest Therapeutics, Inc. | 17.42M | 2.83% | 60,833 | - |
| 491 | BCDA | BioCardia, Inc. | 17.26M | -0.87% | 141,687 | 3.00K |
| 492 | BIVI | BioVie Inc. | 17.20M | 5.56% | 1,551,931 | - |
| 493 | CYCN | Cyclerion Therapeutics, Inc. | 16.95M | -2.90% | 165,546 | 1.90M |
| 494 | PBM | Psyence Biomedical Ltd. | 16.55M | 3.09% | 26,538 | - |
| 495 | CTXR | Citius Pharmaceuticals, Inc. | 15.93M | -3.64% | 281,133 | 7.11M |
| 496 | PLUR | Pluri Inc. | 15.86M | -3.92% | 48,913 | 1.08M |
| 497 | NRSN | NeuroSense Therapeutics Ltd. | 15.78M | 1.50% | 167,910 | - |
| 498 | HIND | Vyome Holdings, Inc. | 15.16M | -2.03% | 7,176 | 129.73K |
| 499 | ADIL | Adial Pharmaceuticals, Inc. | 15.10M | 2.68% | 69,913 | - |
| 500 | AEON | AEON Biopharma, Inc. | 14.76M | -5.82% | 507,909 | - |